0000950170-23-046430.txt : 20230905 0000950170-23-046430.hdr.sgml : 20230905 20230905163606 ACCESSION NUMBER: 0000950170-23-046430 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230901 FILED AS OF DATE: 20230905 DATE AS OF CHANGE: 20230905 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Duke William E. CENTRAL INDEX KEY: 0001636135 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40703 FILM NUMBER: 231236324 MAIL ADDRESS: STREET 1: C/O VALERITAS, INC., 750 ROUTE 202 SOUTH STREET 2: SUITE 600 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invivyd, Inc. CENTRAL INDEX KEY: 0001832038 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851403134 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 178 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 819-0080 MAIL ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 178 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Adagio Therapeutics, Inc. DATE OF NAME CHANGE: 20201112 4 1 ownership.xml 4 X0508 4 2023-09-01 0001832038 Invivyd, Inc. IVVD 0001636135 Duke William E. C/O INVIVYD, INC. 1601 TRAPELO ROAD, SUITE 178 WALTHAM MA 02451 false true false false Chief Financial Officer false Stock Option (Right to Buy) 1.83 2023-09-01 4 A false 750000 0 A 2033-08-31 Common Stock 750000 750000 D This option vests over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the grant date of September 1, 2023 and the remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date. /s/ Jill Andersen attorney-in-fact for William E. Duke 2023-09-05